Have a look at our PowerPoint Introduction and Brochure describing deliverables, differentiators and case studies. Eight case studies can also be reviewed.

The objective of this project was to assist in planning the development of ingredients for infant formula and to help define the ‘ideal’ product.

Arachidonic acid (ARA) is an Omega-6 PUFA found primarily in food sources such as meat, eggs and milk. ARA is a derivative of linoleic acid, derived via gamma-linolenic acid and di homo gamma-linolenic acid. Both DHA (an Omega-3 PUFA) and ARA are building blocks in the infant nervous system and retina and are thought by many experts to be conditionally essential in infancy. A low erucic acid GMO rapeseed plant can produce this ARA in commercial quantities.

Over 100 emails and 150 phone calls were made to 50 key individuals in 12 companies. Face-to-face meetings were held with four companies at their sites and additional face-to-face meetings were held at the ISSFAL 2008 meeting in Kansas with five companies. Further information and background material was obtained via telephone interviews and email from eight further companies.

Click to see the contents of the study or look below for an outline.

Table of Contents

Objective and background

Method and scope

Principal findings

  • Summary of Company Responses
  • Answers to Specific Questions
    1. Canola/Rapeseed oil for infants
    2. Overall impression of our product specifications
    3. Potential adverse fatty acids
    4. Potential added value fatty acids
    5. Comment on the ratio ARA/GLA
    6. Degree of value chain integration
    7. Preferences for formulation
    8. GMO statement/vision
    9. Topics around Martek
    10. Product competitiveness
  • Other Findings



Contact Reports

  • Infant Formula Manufacturers
    • 9 companeis
  • ARA Manufacturers
    • 3 companies
  • Others
    • 2 companies


  • Wake Forest researchers say popular fish contains potentially dangerous fatty acid combination
  • Nestle move spurs Mead Johnson talk
  • Martek Signs Multi-Year Sole-Source Supply Agreement with Numico
  • Martek Signs DHA/ARA License and Supply Agreement With IlDong Foodis for Infant Formula in South Korea
  • Martek Signs Multi-Year Worldwide Sole Source Supply Agreement with Abbott
  • Study finds omega-3 greater anti-inflammatory potential
  • Martek withdraws European patent on ARA oil for infant formula,
  • Martek Signs Multi-Year Infant Formula License and Supply Agreement with Alter Farmacia
  • New European ARA infant formula patent strengthens Martek’s intellectual property position
  • Md.-based Martek Biosciences Corp. lands patent for arachidonic oil,
  • Martek to supply Mead Johnson worldwide with exclusive deal
  • Martek DHA patent upheld in Europe
  • Cargill to market ARA in China joint venture

7 Appendices

2 Tables

Share this project: